Matthias Alder - Chief Executive Officer, Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Matthias Alder - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Matthias Alder for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21.1K $85.8K $4.06 Mar 26, 2024 Direct
Restricted Stock Units 6.38K $24.6K $3.86 Mar 26, 2024 Direct Common Stock
Employee Stock Option (right to buy) 370K Mar 21, 2024 Direct Common Stock

Transactions reported by Matthias Alder for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.